RiboEdge Biotech is a Johannesburg-based biotechnology startup pioneering RNA-based therapeutics for neglected infectious diseases in Africa starting with Crimean-Congo Hemorrhagic Fever (CCHF).
With a focus on siRNA drug design, we are developing precision therapies that silence key viral genes of CCHFV, a deadly BSL-4 pathogen endemic in parts of Africa, Europe, and Asia.
We combine bioinformatics, RNA biology, and African disease insights to deliver scalable, data-driven therapeutic solutions that address the continent’s most overlooked viral threats.
Our long-term vision is to build Africa’s first RNA therapeutics powerhouse—one that translates world-class science into real-world public health impact.
Company Details
- Employees
- 1
- Founded
- -
- Address
- Johannesburg, Midrand 1682, Za
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.riboedgebiotech.com
- Keywords
- RNA Therapeutics, Infectious Disease Research, Vaccine Development, Antiviral Therapies, Biotechnology Innovation, Genomic Medicine, Global Health Solution, Drug Development.
- HQ
- Johannesburg, Midrand
Riboedge Biotech Questions
Riboedge Biotech's website is http://www.riboedgebiotech.com
Riboedge Biotech's LinkedIn profile is https://za.linkedin.com/company/riboedgebiotech
Riboedge Biotech has
1 employees.
View email and phone details for 1
employees at Riboedge Biotech.
Riboedge Biotech's industry is
Biotechnology Research
Riboedge Biotech's categories are Biotechnology Research
Riboedge Biotech's founding year is 2025
